Page 242 - 北京京煤集团总医院第十届·2022学术年会论文集

北京京煤集团总医院 第十届·2022 学术年会论文集

Analysis. Front Pharmacol. 2022;13:852536.

39. Liu Y, Miao Y, Gao X, Wang YY, Wang H, Zheng YW, et al. MicroRNA-200a Affects the

Proliferation of Airway Smooth Muscle Cells and Airway Remodeling by Targeting FOXC1 via
the PI3K/AKT Signaling Pathway in Ovalbumin-Induced Asthmatic Mice. Cell Physiol Biochem.

2018;50(6):2365-89.
40. Zhu J, Wang W, Wu X. Isorhynchophylline exerts anti-asthma effects in mice by inhibiting the

proliferation of airway smooth muscle cells: The involvement of miR-200a-mediated FOXC1/

NF-κB pathway. Biochem Biophys Res Commun. 2020;521(4):1055-60.

41. Islam T, Rahman MR, Aydin B, Beklen H, Arga KY, Shahjaman M. Integrative transcriptomics

analysis of lung epithelial cells and identification of repurposable drug candidates for COVID-19.

Eur J Pharmacol. 2020;887:173594.

42. Samy A, Maher MA, Abdelsalam NA, Badr E. SARS-CoV-2 potential drugs, drug targets, and

biomarkers: a viral-host interaction network-based analysis. Sci Rep. 2022;12(1):11934.

43. Han M, Pandey D. ZMPSTE24 Regulates SARS-CoV-2 Spike Protein-enhanced Expression of

Endothelial PAI-1. Am J Respir Cell Mol Biol. 2021;65(3):300-8.

44. Cho J, Lee YJ, Kim JH, Kim SI, Kim SS, Choi BS, et al. Antiviral activity of digoxin and
ouabain against SARS-CoV-2 infection and its implication for COVID-19. Sci Rep. 2020;

10(1):16200.
45. Sajid Jamal QM, Alharbi AH, Ahmad V. Identification of doxorubicin as a potential

therapeutic against SARS-CoV-2 (COVID-19) protease: a molecular docking and dynamics

simulation studies. J Biomol Struct Dyn. 2021:1-15.

46. Chen WY, Fang ZX, Lv XD, Zhou QH, Yao M, Deng M. Prediction of potential therapeutic

drugs against SARS-CoV-2 by using Connectivity Map based on transcriptome data. Eur Rev Med

Pharmacol Sci. 2021;25(7):3122-31.

- 237 -